A detailed history of Clear Alpha Technologies LP transactions in Organon & Co. stock. As of the latest transaction made, Clear Alpha Technologies LP holds 14,932 shares of OGN stock, worth $224,875. This represents 0.08% of its overall portfolio holdings.

Number of Shares
14,932
Holding current value
$224,875
% of portfolio
0.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.65 - $23.03 $278,481 - $343,883
14,932 New
14,932 $286 Million
Q4 2023

Feb 12, 2024

BUY
$10.95 - $17.32 $452,464 - $715,679
41,321 New
41,321 $596 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.83B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Clear Alpha Technologies LP Portfolio

Follow Clear Alpha Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Alpha Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Clear Alpha Technologies LP with notifications on news.